The safety profile of retatrutide is similar to other incretin-based therapies, with the most commonly reported adverse events being transient and mostly mild to moderate gastrointestinal symptoms, with the 4 mg starting dose group having a higher incidence than the 2 mg starting dose group
By acting as a ligand, microbial butyrate participates in anti-inflammatory reactions to cease the inflammation and maintain gut homeostasis through the aryl hydrocarbon receptor (AhR) and various G-protein coupled receptors (GPCRs) such as GPR109a, GPR43, and GPR41 (Marinelli et al., 2019
They're metabolic interventions that directly influence whether your body stores or burns fat
When introduced into the system, these agents reduce hunger signals and extend satiety after meals
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers